Cargando…

AZD-1222/tozinameran: Leukocytoclastic vasculitis and pityriasis rosea: 2 case reports

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9226840/ http://dx.doi.org/10.1007/s40278-022-17814-1

Ejemplares similares

AZD-1222: Leukocytoclastic vasculitis: case report
Publicado: (2022)

AZD-1222: Leukocytoclastic vasculitis: 2 case reports
Publicado: (2022)

AZD-1222: Papulovesicular pityriasis rosea-like eruption: case report
Publicado: (2021)

Tozinameran: Leukocytoclastic Vasculitis: case report
Publicado: (2022)

AZD-1222/tozinameran: Flares of mixed cryoglobulinaemia vasculitis: 6 case reports
Publicado: (2022)

AZD-1222/sars-cov-2-vaccine-inactivated-sinovac-biotech: Anaphylaxis and pityriasis rosea: case report
Publicado: (2022)

AZD 1222/tozinameran: Diabetes: 2 case reports
Publicado: (2022)

Tozinameran: Leukocytoclastic vasculitis exacerbation: case report
Publicado: (2021)

AZD-1222: Pityriasis rubra pilaris: case report
Publicado: (2022)

AZD-1222/tozinameran: Subacute thyroiditis: 2 case reports
Publicado: (2022)

AZD-1222/tozinameran: Haemophagocytic-lymphohistiocytosis: 2 case reports
Publicado: (2022)

AZD-1222/tozinameran: Immune thrombocytopenia: 10 case reports
Publicado: (2022)

AZD-1222/tozinameran: Various toxicities: 3 case reports
Publicado: (2022)

Azd-1222/tozinameran: Primary podocytopathy: 4 case reports
Publicado: (2022)

AZD-1222: Urticarial vasculitis: case report
Publicado: (2022)

AZD-1222: Leucocytoclastic vasculitis: case report
Publicado: (2022)

Azd-1222/tozinameran: Guillain-Barre syndrome: 13 case reports
Publicado: (2022)

AZD-1222/elasomeran/tozinameran: Various toxicities: 5 case reports
Publicado: (2022)

Azd-1222/tozinameran: Arterial and venous thrombosis: 17 case reports
Publicado: (2022)

AZD-1222: Cutaneous lymphocytic vasculitis: case report
Publicado: (2022)

AZD-1222: ANCA-associated vasculitis: case report
Publicado: (2022)

AZD-1222: Immunoglobulin A vasculitis: case report
Publicado: (2021)

AZD-1222/tozinameran: Graves' disease and focal painful thyroiditis: 2 case reports
Publicado: (2022)

Azd-1222: Inflammatory myositis and vasculitis: 3 case reports
Publicado: (2022)

Azd-1222: Cutaneous small-vessel vasculitis: case report
Publicado: (2022)

Azd-1222: Small-vessel cutaneous vasculitis: case report
Publicado: (2022)

AZD-1222/mRNA-1273/tozinameran: Acute pancreatitis : 8 case reports
Publicado: (2021)

Azd-1222/mrna-1273/tozinameran: Retinal vascular event: 6 case reports
Publicado: (2021)

Tozinameran: Immunoglobulin A-dominant leukocytoclastic vasculitis (Henoch-Schonlein purpura): case report
Publicado: (2022)

AZD-1222/elasomeran/tozinameran: Multiple sclerosis (MS) and relapse of MS: 16 case reports
Publicado: (2022)

AZD-1222/tozinameran: Neurological complications post COVID-19 vaccination: 18 case reports
Publicado: (2022)

AZD-1222/tozinameran: Varicella zoster virus-induced neurological disease: 3 case reports
Publicado: (2022)

AZD-1222/immune-globulin/tozinameran: Guillain-Barre-syndrome and lack of efficacy: 2 case reports
Publicado: (2021)

GIANT PITYRIASIS ROSEA
por: Zawar, Vijay
Publicado: (2010)

Recurrent pityriasis rosea: A case report
por: Li, Ang, et al.
Publicado: (2017)

Azd-1222: Anti-Neutrophil Cytoplasmic Antibody-associated vasculitis: case report
Publicado: (2022)

AZD-1222: Severe bullous pemphigoid and IgA vasculitis: case report
Publicado: (2022)

Azd-1222/nonsteroidal-anti-inflammatories/tozinameran: Minimal change disease and acute interstitial nephritis: 2 case reports
Publicado: (2022)

Dupilumab-induced pityriasis rosea
por: Zabel, Morgan, et al.
Publicado: (2023)

AZD-1222/tozinameran: Immune thrombocytopenia and exacerbation of pre-existing chronic immune thrombocytopenia: 4 case reports
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_h2khbe9ik3e3nh86ij6ikcuor9